Therefore, we reasoned that SPI1 risk allele carriers have higher expression of PU.1, leading to enhanced neuroinflammatory responses to peripheral chronic inflammation, which may increase their risk of AD. This evidence concerns the gene SPI1 and Alzheimer disease.